nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylcysteine—Mediastinal disorder—Erlotinib—pancreatic cancer	0.00229	0.00662	CcSEcCtD
Acetylcysteine—Haemoptysis—Epirubicin—pancreatic cancer	0.00227	0.00657	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Fluorouracil—pancreatic cancer	0.00224	0.00648	CcSEcCtD
Acetylcysteine—Erythema—Tamoxifen—pancreatic cancer	0.00223	0.00646	CcSEcCtD
Acetylcysteine—Erythema—Erlotinib—pancreatic cancer	0.00221	0.00639	CcSEcCtD
Acetylcysteine—Bronchospasm—Gemcitabine—pancreatic cancer	0.00217	0.00627	CcSEcCtD
Acetylcysteine—Feeling hot—Epirubicin—pancreatic cancer	0.00214	0.0062	CcSEcCtD
Acetylcysteine—Haemoptysis—Doxorubicin—pancreatic cancer	0.0021	0.00608	CcSEcCtD
Acetylcysteine—Angioedema—Tamoxifen—pancreatic cancer	0.00204	0.0059	CcSEcCtD
Acetylcysteine—Cardiac disorder—Sunitinib—pancreatic cancer	0.00204	0.0059	CcSEcCtD
Acetylcysteine—Flushing—Sunitinib—pancreatic cancer	0.00204	0.0059	CcSEcCtD
Acetylcysteine—Angiopathy—Sunitinib—pancreatic cancer	0.00199	0.00577	CcSEcCtD
Acetylcysteine—Immune system disorder—Sunitinib—pancreatic cancer	0.00199	0.00574	CcSEcCtD
Acetylcysteine—Syncope—Erlotinib—pancreatic cancer	0.00198	0.00573	CcSEcCtD
Acetylcysteine—Feeling hot—Doxorubicin—pancreatic cancer	0.00198	0.00573	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Sunitinib—pancreatic cancer	0.00198	0.00573	CcSEcCtD
Acetylcysteine—Stomatitis—Irinotecan—pancreatic cancer	0.00197	0.00569	CcSEcCtD
Acetylcysteine—Cough—Tamoxifen—pancreatic cancer	0.00195	0.00564	CcSEcCtD
Acetylcysteine—Loss of consciousness—Erlotinib—pancreatic cancer	0.00194	0.00562	CcSEcCtD
Acetylcysteine—Sweating—Irinotecan—pancreatic cancer	0.00193	0.00559	CcSEcCtD
Acetylcysteine—Cough—Erlotinib—pancreatic cancer	0.00193	0.00558	CcSEcCtD
Acetylcysteine—Stomatitis—Gemcitabine—pancreatic cancer	0.00191	0.00554	CcSEcCtD
Acetylcysteine—Erythema—Sunitinib—pancreatic cancer	0.00191	0.00553	CcSEcCtD
Acetylcysteine—Sweating—Gemcitabine—pancreatic cancer	0.00188	0.00545	CcSEcCtD
Acetylcysteine—Stomatitis—Fluorouracil—pancreatic cancer	0.00188	0.00545	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—pancreatic cancer	0.00187	0.00541	CcSEcCtD
Acetylcysteine—Thinking abnormal—Epirubicin—pancreatic cancer	0.00184	0.00531	CcSEcCtD
Acetylcysteine—Oedema—Tamoxifen—pancreatic cancer	0.00182	0.00527	CcSEcCtD
Acetylcysteine—Oedema—Erlotinib—pancreatic cancer	0.0018	0.00522	CcSEcCtD
Acetylcysteine—Shock—Erlotinib—pancreatic cancer	0.00177	0.00513	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Tamoxifen—pancreatic cancer	0.00176	0.0051	CcSEcCtD
Acetylcysteine—Skin disorder—Erlotinib—pancreatic cancer	0.00175	0.00507	CcSEcCtD
Acetylcysteine—Pharyngitis—Gemcitabine—pancreatic cancer	0.00175	0.00506	CcSEcCtD
Acetylcysteine—Angioedema—Sunitinib—pancreatic cancer	0.00175	0.00506	CcSEcCtD
Acetylcysteine—Gait disturbance—Epirubicin—pancreatic cancer	0.00172	0.00498	CcSEcCtD
Acetylcysteine—Pharyngitis—Fluorouracil—pancreatic cancer	0.00172	0.00498	CcSEcCtD
Acetylcysteine—Thinking abnormal—Doxorubicin—pancreatic cancer	0.0017	0.00491	CcSEcCtD
Acetylcysteine—Flushing—Irinotecan—pancreatic cancer	0.00168	0.00486	CcSEcCtD
Acetylcysteine—Cardiac disorder—Irinotecan—pancreatic cancer	0.00168	0.00486	CcSEcCtD
Acetylcysteine—Cough—Sunitinib—pancreatic cancer	0.00167	0.00483	CcSEcCtD
Acetylcysteine—Angiopathy—Irinotecan—pancreatic cancer	0.00164	0.00475	CcSEcCtD
Acetylcysteine—Cardiac disorder—Gemcitabine—pancreatic cancer	0.00164	0.00473	CcSEcCtD
Acetylcysteine—Immune system disorder—Irinotecan—pancreatic cancer	0.00164	0.00473	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Irinotecan—pancreatic cancer	0.00163	0.00472	CcSEcCtD
Acetylcysteine—Dyspnoea—Tamoxifen—pancreatic cancer	0.00163	0.0047	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Docetaxel—pancreatic cancer	0.00162	0.00468	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.00162	0.00468	CcSEcCtD
Acetylcysteine—Dyspnoea—Erlotinib—pancreatic cancer	0.00161	0.00465	CcSEcCtD
Acetylcysteine—Dyspepsia—Tamoxifen—pancreatic cancer	0.0016	0.00464	CcSEcCtD
Acetylcysteine—Angiopathy—Gemcitabine—pancreatic cancer	0.0016	0.00463	CcSEcCtD
Acetylcysteine—Gait disturbance—Doxorubicin—pancreatic cancer	0.00159	0.00461	CcSEcCtD
Acetylcysteine—Immune system disorder—Gemcitabine—pancreatic cancer	0.00159	0.00461	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Gemcitabine—pancreatic cancer	0.00159	0.0046	CcSEcCtD
Acetylcysteine—Dyspepsia—Erlotinib—pancreatic cancer	0.00159	0.00459	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.00157	0.00455	CcSEcCtD
Acetylcysteine—Oedema—Sunitinib—pancreatic cancer	0.00156	0.00452	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.00156	0.0045	CcSEcCtD
Acetylcysteine—Bronchospasm—Docetaxel—pancreatic cancer	0.00154	0.00445	CcSEcCtD
Acetylcysteine—Shock—Sunitinib—pancreatic cancer	0.00154	0.00444	CcSEcCtD
Acetylcysteine—Erythema—Gemcitabine—pancreatic cancer	0.00154	0.00444	CcSEcCtD
Acetylcysteine—Skin disorder—Sunitinib—pancreatic cancer	0.00152	0.00439	CcSEcCtD
Acetylcysteine—Erythema—Fluorouracil—pancreatic cancer	0.00151	0.00437	CcSEcCtD
Acetylcysteine—Mental disability—Epirubicin—pancreatic cancer	0.00146	0.00422	CcSEcCtD
Acetylcysteine—Urticaria—Tamoxifen—pancreatic cancer	0.00145	0.00419	CcSEcCtD
Acetylcysteine—Body temperature increased—Erlotinib—pancreatic cancer	0.00143	0.00412	CcSEcCtD
Acetylcysteine—Syncope—Irinotecan—pancreatic cancer	0.00141	0.00409	CcSEcCtD
Acetylcysteine—Dyspnoea—Sunitinib—pancreatic cancer	0.00139	0.00403	CcSEcCtD
Acetylcysteine—Loss of consciousness—Irinotecan—pancreatic cancer	0.00139	0.00401	CcSEcCtD
Acetylcysteine—Cough—Irinotecan—pancreatic cancer	0.00138	0.00398	CcSEcCtD
Acetylcysteine—Dyspepsia—Sunitinib—pancreatic cancer	0.00137	0.00398	CcSEcCtD
Acetylcysteine—Stomatitis—Docetaxel—pancreatic cancer	0.00136	0.00393	CcSEcCtD
Acetylcysteine—Eye pain—Epirubicin—pancreatic cancer	0.00135	0.00391	CcSEcCtD
Acetylcysteine—Mental disability—Doxorubicin—pancreatic cancer	0.00135	0.0039	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.00135	0.0039	CcSEcCtD
Acetylcysteine—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00134	0.00389	CcSEcCtD
Acetylcysteine—Cough—Gemcitabine—pancreatic cancer	0.00134	0.00388	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.0013	0.00375	CcSEcCtD
Acetylcysteine—Pruritus—Tamoxifen—pancreatic cancer	0.00129	0.00373	CcSEcCtD
Acetylcysteine—Oedema—Irinotecan—pancreatic cancer	0.00129	0.00372	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Irinotecan—pancreatic cancer	0.00129	0.00372	CcSEcCtD
Acetylcysteine—Pruritus—Erlotinib—pancreatic cancer	0.00128	0.00369	CcSEcCtD
Acetylcysteine—Shock—Irinotecan—pancreatic cancer	0.00127	0.00366	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Epirubicin—pancreatic cancer	0.00126	0.00365	CcSEcCtD
Acetylcysteine—Oedema—Gemcitabine—pancreatic cancer	0.00125	0.00362	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.00125	0.00362	CcSEcCtD
Acetylcysteine—Eye pain—Doxorubicin—pancreatic cancer	0.00125	0.00362	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Irinotecan—pancreatic cancer	0.00124	0.0036	CcSEcCtD
Acetylcysteine—Pharyngitis—Docetaxel—pancreatic cancer	0.00124	0.00359	CcSEcCtD
Acetylcysteine—Body temperature increased—Sunitinib—pancreatic cancer	0.00123	0.00357	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.00123	0.00356	CcSEcCtD
Acetylcysteine—Oedema—Fluorouracil—pancreatic cancer	0.00123	0.00356	CcSEcCtD
Acetylcysteine—Skin disorder—Gemcitabine—pancreatic cancer	0.00122	0.00352	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.00121	0.0035	CcSEcCtD
Acetylcysteine—Dizziness—Tamoxifen—pancreatic cancer	0.00121	0.00349	CcSEcCtD
Acetylcysteine—Tachycardia—Fluorouracil—pancreatic cancer	0.0012	0.00348	CcSEcCtD
Acetylcysteine—Hypotension—Irinotecan—pancreatic cancer	0.0012	0.00348	CcSEcCtD
Acetylcysteine—Dizziness—Erlotinib—pancreatic cancer	0.00119	0.00345	CcSEcCtD
Acetylcysteine—Face oedema—Epirubicin—pancreatic cancer	0.00118	0.00341	CcSEcCtD
Acetylcysteine—Hypotension—Gemcitabine—pancreatic cancer	0.00117	0.00339	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.00117	0.00337	CcSEcCtD
Acetylcysteine—Cardiac disorder—Docetaxel—pancreatic cancer	0.00116	0.00336	CcSEcCtD
Acetylcysteine—Flushing—Docetaxel—pancreatic cancer	0.00116	0.00336	CcSEcCtD
Acetylcysteine—Vomiting—Tamoxifen—pancreatic cancer	0.00116	0.00335	CcSEcCtD
Acetylcysteine—Hypotension—Fluorouracil—pancreatic cancer	0.00115	0.00333	CcSEcCtD
Acetylcysteine—Hypersensitivity—Sunitinib—pancreatic cancer	0.00115	0.00333	CcSEcCtD
Acetylcysteine—Rash—Tamoxifen—pancreatic cancer	0.00115	0.00333	CcSEcCtD
Acetylcysteine—Dermatitis—Tamoxifen—pancreatic cancer	0.00115	0.00332	CcSEcCtD
Acetylcysteine—Vomiting—Erlotinib—pancreatic cancer	0.00115	0.00332	CcSEcCtD
Acetylcysteine—Dyspnoea—Irinotecan—pancreatic cancer	0.00115	0.00332	CcSEcCtD
Acetylcysteine—Somnolence—Irinotecan—pancreatic cancer	0.00114	0.00331	CcSEcCtD
Acetylcysteine—Rash—Erlotinib—pancreatic cancer	0.00114	0.00329	CcSEcCtD
Acetylcysteine—Dermatitis—Erlotinib—pancreatic cancer	0.00114	0.00329	CcSEcCtD
Acetylcysteine—Angiopathy—Docetaxel—pancreatic cancer	0.00114	0.00328	CcSEcCtD
Acetylcysteine—Dyspepsia—Irinotecan—pancreatic cancer	0.00113	0.00328	CcSEcCtD
Acetylcysteine—Immune system disorder—Docetaxel—pancreatic cancer	0.00113	0.00327	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Docetaxel—pancreatic cancer	0.00113	0.00326	CcSEcCtD
Acetylcysteine—Dyspnoea—Gemcitabine—pancreatic cancer	0.00112	0.00323	CcSEcCtD
Acetylcysteine—Somnolence—Gemcitabine—pancreatic cancer	0.00111	0.00322	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00111	0.00321	CcSEcCtD
Acetylcysteine—Pruritus—Sunitinib—pancreatic cancer	0.0011	0.0032	CcSEcCtD
Acetylcysteine—Dyspnoea—Fluorouracil—pancreatic cancer	0.0011	0.00318	CcSEcCtD
Acetylcysteine—Somnolence—Fluorouracil—pancreatic cancer	0.0011	0.00317	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Epirubicin—pancreatic cancer	0.00109	0.00316	CcSEcCtD
Acetylcysteine—Face oedema—Doxorubicin—pancreatic cancer	0.00109	0.00315	CcSEcCtD
Acetylcysteine—Erythema—Docetaxel—pancreatic cancer	0.00109	0.00315	CcSEcCtD
Acetylcysteine—Dyspepsia—Fluorouracil—pancreatic cancer	0.00108	0.00314	CcSEcCtD
Acetylcysteine—Nausea—Tamoxifen—pancreatic cancer	0.00108	0.00313	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.00108	0.00313	CcSEcCtD
Acetylcysteine—Nausea—Erlotinib—pancreatic cancer	0.00107	0.0031	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00106	0.00308	CcSEcCtD
Acetylcysteine—Asthma—Epirubicin—pancreatic cancer	0.00105	0.00305	CcSEcCtD
Acetylcysteine—Dizziness—Sunitinib—pancreatic cancer	0.00103	0.00299	CcSEcCtD
Acetylcysteine—Body temperature increased—Irinotecan—pancreatic cancer	0.00102	0.00294	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.00101	0.00292	CcSEcCtD
Acetylcysteine—Vomiting—Sunitinib—pancreatic cancer	0.000993	0.00287	CcSEcCtD
Acetylcysteine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000991	0.00287	CcSEcCtD
Acetylcysteine—Rash—Sunitinib—pancreatic cancer	0.000985	0.00285	CcSEcCtD
Acetylcysteine—Dermatitis—Sunitinib—pancreatic cancer	0.000984	0.00285	CcSEcCtD
Acetylcysteine—Urticaria—Fluorouracil—pancreatic cancer	0.000979	0.00283	CcSEcCtD
Acetylcysteine—Syncope—Docetaxel—pancreatic cancer	0.000977	0.00283	CcSEcCtD
Acetylcysteine—Asthma—Doxorubicin—pancreatic cancer	0.000976	0.00282	CcSEcCtD
Acetylcysteine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000974	0.00282	CcSEcCtD
Acetylcysteine—Loss of consciousness—Docetaxel—pancreatic cancer	0.000958	0.00277	CcSEcCtD
Acetylcysteine—Cough—Docetaxel—pancreatic cancer	0.000951	0.00275	CcSEcCtD
Acetylcysteine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000948	0.00274	CcSEcCtD
Acetylcysteine—Drowsiness—Epirubicin—pancreatic cancer	0.00094	0.00272	CcSEcCtD
Acetylcysteine—Nausea—Sunitinib—pancreatic cancer	0.000928	0.00268	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000921	0.00266	CcSEcCtD
Acetylcysteine—Stomatitis—Epirubicin—pancreatic cancer	0.000917	0.00265	CcSEcCtD
Acetylcysteine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000908	0.00263	CcSEcCtD
Acetylcysteine—Sweating—Epirubicin—pancreatic cancer	0.000902	0.00261	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000889	0.00257	CcSEcCtD
Acetylcysteine—Oedema—Docetaxel—pancreatic cancer	0.000889	0.00257	CcSEcCtD
Acetylcysteine—Pruritus—Gemcitabine—pancreatic cancer	0.000886	0.00256	CcSEcCtD
Acetylcysteine—ACY1—digestive system—pancreatic cancer	0.000877	0.155	CbGeAlD
Acetylcysteine—Shock—Docetaxel—pancreatic cancer	0.000875	0.00253	CcSEcCtD
Acetylcysteine—Pruritus—Fluorouracil—pancreatic cancer	0.000872	0.00252	CcSEcCtD
Acetylcysteine—Drowsiness—Doxorubicin—pancreatic cancer	0.00087	0.00252	CcSEcCtD
Acetylcysteine—Tachycardia—Docetaxel—pancreatic cancer	0.000868	0.00251	CcSEcCtD
Acetylcysteine—Skin disorder—Docetaxel—pancreatic cancer	0.000864	0.0025	CcSEcCtD
Acetylcysteine—Dizziness—Irinotecan—pancreatic cancer	0.000851	0.00246	CcSEcCtD
Acetylcysteine—Stomatitis—Doxorubicin—pancreatic cancer	0.000848	0.00245	CcSEcCtD
Acetylcysteine—Pharyngitis—Epirubicin—pancreatic cancer	0.000838	0.00242	CcSEcCtD
Acetylcysteine—Sweating—Doxorubicin—pancreatic cancer	0.000834	0.00241	CcSEcCtD
Acetylcysteine—Hypotension—Docetaxel—pancreatic cancer	0.000831	0.0024	CcSEcCtD
Acetylcysteine—SLC7A11—islet of Langerhans—pancreatic cancer	0.00083	0.147	CbGeAlD
Acetylcysteine—Vomiting—Irinotecan—pancreatic cancer	0.000818	0.00237	CcSEcCtD
Acetylcysteine—Dizziness—Fluorouracil—pancreatic cancer	0.000815	0.00236	CcSEcCtD
Acetylcysteine—Rash—Irinotecan—pancreatic cancer	0.000811	0.00235	CcSEcCtD
Acetylcysteine—Dermatitis—Irinotecan—pancreatic cancer	0.00081	0.00234	CcSEcCtD
Acetylcysteine—Vomiting—Gemcitabine—pancreatic cancer	0.000797	0.0023	CcSEcCtD
Acetylcysteine—Dyspnoea—Docetaxel—pancreatic cancer	0.000793	0.00229	CcSEcCtD
Acetylcysteine—Somnolence—Docetaxel—pancreatic cancer	0.00079	0.00229	CcSEcCtD
Acetylcysteine—Rash—Gemcitabine—pancreatic cancer	0.00079	0.00229	CcSEcCtD
Acetylcysteine—Dermatitis—Gemcitabine—pancreatic cancer	0.000789	0.00228	CcSEcCtD
Acetylcysteine—Flushing—Epirubicin—pancreatic cancer	0.000783	0.00227	CcSEcCtD
Acetylcysteine—Cardiac disorder—Epirubicin—pancreatic cancer	0.000783	0.00227	CcSEcCtD
Acetylcysteine—Vomiting—Fluorouracil—pancreatic cancer	0.000783	0.00227	CcSEcCtD
Acetylcysteine—Dyspepsia—Docetaxel—pancreatic cancer	0.000783	0.00226	CcSEcCtD
Acetylcysteine—Rash—Fluorouracil—pancreatic cancer	0.000777	0.00225	CcSEcCtD
Acetylcysteine—Dermatitis—Fluorouracil—pancreatic cancer	0.000776	0.00224	CcSEcCtD
Acetylcysteine—Pharyngitis—Doxorubicin—pancreatic cancer	0.000775	0.00224	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000768	0.00222	CcSEcCtD
Acetylcysteine—Angiopathy—Epirubicin—pancreatic cancer	0.000766	0.00222	CcSEcCtD
Acetylcysteine—Nausea—Irinotecan—pancreatic cancer	0.000764	0.00221	CcSEcCtD
Acetylcysteine—Immune system disorder—Epirubicin—pancreatic cancer	0.000763	0.00221	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000761	0.0022	CcSEcCtD
Acetylcysteine—Nausea—Gemcitabine—pancreatic cancer	0.000744	0.00215	CcSEcCtD
Acetylcysteine—Erythema—Epirubicin—pancreatic cancer	0.000735	0.00213	CcSEcCtD
Acetylcysteine—Nausea—Fluorouracil—pancreatic cancer	0.000732	0.00212	CcSEcCtD
Acetylcysteine—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000725	0.0021	CcSEcCtD
Acetylcysteine—Flushing—Doxorubicin—pancreatic cancer	0.000725	0.0021	CcSEcCtD
Acetylcysteine—Angiopathy—Doxorubicin—pancreatic cancer	0.000709	0.00205	CcSEcCtD
Acetylcysteine—Immune system disorder—Doxorubicin—pancreatic cancer	0.000706	0.00204	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000704	0.00204	CcSEcCtD
Acetylcysteine—Body temperature increased—Docetaxel—pancreatic cancer	0.000703	0.00203	CcSEcCtD
Acetylcysteine—Erythema—Doxorubicin—pancreatic cancer	0.00068	0.00197	CcSEcCtD
Acetylcysteine—GSS—islet of Langerhans—pancreatic cancer	0.000673	0.119	CbGeAlD
Acetylcysteine—Syncope—Epirubicin—pancreatic cancer	0.000659	0.00191	CcSEcCtD
Acetylcysteine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000655	0.00189	CcSEcCtD
Acetylcysteine—Loss of consciousness—Epirubicin—pancreatic cancer	0.000646	0.00187	CcSEcCtD
Acetylcysteine—Cough—Epirubicin—pancreatic cancer	0.000641	0.00185	CcSEcCtD
Acetylcysteine—Pruritus—Docetaxel—pancreatic cancer	0.000629	0.00182	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000621	0.0018	CcSEcCtD
Acetylcysteine—Syncope—Doxorubicin—pancreatic cancer	0.00061	0.00176	CcSEcCtD
Acetylcysteine—CHUK—digestive system—pancreatic cancer	0.000605	0.107	CbGeAlD
Acetylcysteine—Oedema—Epirubicin—pancreatic cancer	0.0006	0.00173	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Epirubicin—pancreatic cancer	0.0006	0.00173	CcSEcCtD
Acetylcysteine—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000598	0.00173	CcSEcCtD
Acetylcysteine—Cough—Doxorubicin—pancreatic cancer	0.000593	0.00172	CcSEcCtD
Acetylcysteine—Shock—Epirubicin—pancreatic cancer	0.00059	0.00171	CcSEcCtD
Acetylcysteine—Dizziness—Docetaxel—pancreatic cancer	0.000588	0.0017	CcSEcCtD
Acetylcysteine—Tachycardia—Epirubicin—pancreatic cancer	0.000585	0.00169	CcSEcCtD
Acetylcysteine—SLC7A11—pancreas—pancreatic cancer	0.000584	0.103	CbGeAlD
Acetylcysteine—Skin disorder—Epirubicin—pancreatic cancer	0.000583	0.00169	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.00058	0.00168	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000575	0.00166	CcSEcCtD
Acetylcysteine—Vomiting—Docetaxel—pancreatic cancer	0.000565	0.00164	CcSEcCtD
Acetylcysteine—Rash—Docetaxel—pancreatic cancer	0.000561	0.00162	CcSEcCtD
Acetylcysteine—Hypotension—Epirubicin—pancreatic cancer	0.00056	0.00162	CcSEcCtD
Acetylcysteine—Dermatitis—Docetaxel—pancreatic cancer	0.00056	0.00162	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000555	0.00161	CcSEcCtD
Acetylcysteine—Oedema—Doxorubicin—pancreatic cancer	0.000555	0.00161	CcSEcCtD
Acetylcysteine—Shock—Doxorubicin—pancreatic cancer	0.000546	0.00158	CcSEcCtD
Acetylcysteine—Tachycardia—Doxorubicin—pancreatic cancer	0.000542	0.00157	CcSEcCtD
Acetylcysteine—Skin disorder—Doxorubicin—pancreatic cancer	0.000539	0.00156	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000536	0.00155	CcSEcCtD
Acetylcysteine—Dyspnoea—Epirubicin—pancreatic cancer	0.000535	0.00155	CcSEcCtD
Acetylcysteine—Somnolence—Epirubicin—pancreatic cancer	0.000533	0.00154	CcSEcCtD
Acetylcysteine—Nausea—Docetaxel—pancreatic cancer	0.000528	0.00153	CcSEcCtD
Acetylcysteine—Dyspepsia—Epirubicin—pancreatic cancer	0.000528	0.00153	CcSEcCtD
Acetylcysteine—Hypotension—Doxorubicin—pancreatic cancer	0.000519	0.0015	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000518	0.0015	CcSEcCtD
Acetylcysteine—SLC7A11—digestive system—pancreatic cancer	0.000499	0.0882	CbGeAlD
Acetylcysteine—Dyspnoea—Doxorubicin—pancreatic cancer	0.000495	0.00143	CcSEcCtD
Acetylcysteine—Somnolence—Doxorubicin—pancreatic cancer	0.000493	0.00143	CcSEcCtD
Acetylcysteine—Dyspepsia—Doxorubicin—pancreatic cancer	0.000488	0.00141	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000479	0.00139	CcSEcCtD
Acetylcysteine—Urticaria—Epirubicin—pancreatic cancer	0.000476	0.00138	CcSEcCtD
Acetylcysteine—Body temperature increased—Epirubicin—pancreatic cancer	0.000474	0.00137	CcSEcCtD
Acetylcysteine—GSS—pancreas—pancreatic cancer	0.000473	0.0837	CbGeAlD
Acetylcysteine—Hypersensitivity—Epirubicin—pancreatic cancer	0.000442	0.00128	CcSEcCtD
Acetylcysteine—Urticaria—Doxorubicin—pancreatic cancer	0.000441	0.00128	CcSEcCtD
Acetylcysteine—Body temperature increased—Doxorubicin—pancreatic cancer	0.000439	0.00127	CcSEcCtD
Acetylcysteine—Pruritus—Epirubicin—pancreatic cancer	0.000424	0.00123	CcSEcCtD
Acetylcysteine—IKBKB—digestive system—pancreatic cancer	0.000412	0.0728	CbGeAlD
Acetylcysteine—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000409	0.00118	CcSEcCtD
Acetylcysteine—GSS—digestive system—pancreatic cancer	0.000404	0.0715	CbGeAlD
Acetylcysteine—Dizziness—Epirubicin—pancreatic cancer	0.000397	0.00115	CcSEcCtD
Acetylcysteine—Pruritus—Doxorubicin—pancreatic cancer	0.000393	0.00114	CcSEcCtD
Acetylcysteine—Vomiting—Epirubicin—pancreatic cancer	0.000381	0.0011	CcSEcCtD
Acetylcysteine—Rash—Epirubicin—pancreatic cancer	0.000378	0.00109	CcSEcCtD
Acetylcysteine—Dermatitis—Epirubicin—pancreatic cancer	0.000378	0.00109	CcSEcCtD
Acetylcysteine—Dizziness—Doxorubicin—pancreatic cancer	0.000367	0.00106	CcSEcCtD
Acetylcysteine—Nausea—Epirubicin—pancreatic cancer	0.000356	0.00103	CcSEcCtD
Acetylcysteine—Vomiting—Doxorubicin—pancreatic cancer	0.000353	0.00102	CcSEcCtD
Acetylcysteine—Rash—Doxorubicin—pancreatic cancer	0.00035	0.00101	CcSEcCtD
Acetylcysteine—Dermatitis—Doxorubicin—pancreatic cancer	0.00035	0.00101	CcSEcCtD
Acetylcysteine—Nausea—Doxorubicin—pancreatic cancer	0.00033	0.000953	CcSEcCtD
Acetylcysteine—SLCO1B1—digestive system—pancreatic cancer	0.000297	0.0525	CbGeAlD
Acetylcysteine—IKBKB—Signaling Pathways—SCT—pancreatic cancer	0.000101	0.000155	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—HEY1—pancreatic cancer	0.000101	0.000155	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—KRAS—pancreatic cancer	0.0001	0.000155	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—AKT1—pancreatic cancer	0.0001	0.000155	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—CDH1—pancreatic cancer	9.96e-05	0.000154	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—PIK3CD—pancreatic cancer	9.91e-05	0.000153	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—EGFR—pancreatic cancer	9.9e-05	0.000153	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—JAG2—pancreatic cancer	9.84e-05	0.000152	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—AKT1—pancreatic cancer	9.8e-05	0.000151	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—EGF—pancreatic cancer	9.7e-05	0.00015	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MEN1—pancreatic cancer	9.7e-05	0.00015	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—TNF—pancreatic cancer	9.67e-05	0.000149	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—SLC2A2—pancreatic cancer	9.66e-05	0.000149	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—EGFR—pancreatic cancer	9.64e-05	0.000149	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CCK—pancreatic cancer	9.6e-05	0.000148	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—KRAS—pancreatic cancer	9.59e-05	0.000148	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	9.56e-05	0.000147	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—PIK3CD—pancreatic cancer	9.52e-05	0.000147	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IFNA2—pancreatic cancer	9.43e-05	0.000145	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—TNF—pancreatic cancer	9.43e-05	0.000145	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—PIK3CA—pancreatic cancer	9.39e-05	0.000145	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CNR2—pancreatic cancer	9.35e-05	0.000144	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—GLP1R—pancreatic cancer	9.35e-05	0.000144	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—KRAS—pancreatic cancer	9.35e-05	0.000144	CbGpPWpGaD
Acetylcysteine—ACY1—Metabolism—AKT1—pancreatic cancer	9.3e-05	0.000143	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—AKT1—pancreatic cancer	9.29e-05	0.000143	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—PTEN—pancreatic cancer	9.27e-05	0.000143	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—KRAS—pancreatic cancer	9.27e-05	0.000143	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—SHH—pancreatic cancer	9.25e-05	0.000143	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—PIK3CA—pancreatic cancer	9.23e-05	0.000142	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	9.23e-05	0.000142	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CCKAR—pancreatic cancer	9.2e-05	0.000142	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NOTCH4—pancreatic cancer	9.19e-05	0.000142	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IAPP—pancreatic cancer	9.14e-05	0.000141	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—KRAS—pancreatic cancer	9.11e-05	0.00014	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—CDH1—pancreatic cancer	9.03e-05	0.000139	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—PIK3CD—pancreatic cancer	8.99e-05	0.000139	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—JAG2—pancreatic cancer	8.92e-05	0.000138	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MEN1—pancreatic cancer	8.79e-05	0.000136	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PTCH1—pancreatic cancer	8.77e-05	0.000135	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PTHLH—pancreatic cancer	8.77e-05	0.000135	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—HRAS—pancreatic cancer	8.69e-05	0.000134	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—PIK3CB—pancreatic cancer	8.64e-05	0.000133	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—PIK3CD—pancreatic cancer	8.63e-05	0.000133	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—HRAS—pancreatic cancer	8.54e-05	0.000132	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—PIK3CA—pancreatic cancer	8.51e-05	0.000131	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—SMAD4—pancreatic cancer	8.41e-05	0.00013	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	8.4e-05	0.00013	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—SHH—pancreatic cancer	8.39e-05	0.000129	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—PIK3CA—pancreatic cancer	8.37e-05	0.000129	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NOTCH4—pancreatic cancer	8.34e-05	0.000129	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—PIK3CB—pancreatic cancer	8.29e-05	0.000128	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IAPP—pancreatic cancer	8.29e-05	0.000128	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—HES1—pancreatic cancer	8.21e-05	0.000127	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—HRAS—pancreatic cancer	8.15e-05	0.000126	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—SST—pancreatic cancer	8.02e-05	0.000124	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PTHLH—pancreatic cancer	7.95e-05	0.000123	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PTCH1—pancreatic cancer	7.95e-05	0.000123	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—HRAS—pancreatic cancer	7.95e-05	0.000123	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—HRAS—pancreatic cancer	7.88e-05	0.000121	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—JAG1—pancreatic cancer	7.85e-05	0.000121	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—PIK3CB—pancreatic cancer	7.83e-05	0.000121	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NOTCH3—pancreatic cancer	7.82e-05	0.000121	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—HRAS—pancreatic cancer	7.74e-05	0.000119	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—CTNNB1—pancreatic cancer	7.66e-05	0.000118	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—AKT1—pancreatic cancer	7.54e-05	0.000116	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—PIK3CB—pancreatic cancer	7.52e-05	0.000116	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CD44—pancreatic cancer	7.48e-05	0.000115	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—BCL2L1—pancreatic cancer	7.48e-05	0.000115	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—PTEN—pancreatic cancer	7.46e-05	0.000115	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—TSC2—pancreatic cancer	7.43e-05	0.000115	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CNR1—pancreatic cancer	7.4e-05	0.000114	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	7.33e-05	0.000113	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—SST—pancreatic cancer	7.27e-05	0.000112	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	7.26e-05	0.000112	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—AKT1—pancreatic cancer	7.2e-05	0.000111	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—TERT—pancreatic cancer	7.19e-05	0.000111	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—GCG—pancreatic cancer	7.17e-05	0.000111	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—PTEN—pancreatic cancer	7.17e-05	0.00011	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—GCG—pancreatic cancer	7.15e-05	0.00011	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—JAG1—pancreatic cancer	7.12e-05	0.00011	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NOTCH3—pancreatic cancer	7.09e-05	0.000109	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—AKT1—pancreatic cancer	7.02e-05	0.000108	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—CTNNB1—pancreatic cancer	6.94e-05	0.000107	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—SRC—pancreatic cancer	6.92e-05	0.000107	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—HIF1A—pancreatic cancer	6.88e-05	0.000106	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—TSC2—pancreatic cancer	6.86e-05	0.000106	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—AKT1—pancreatic cancer	6.84e-05	0.000105	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—AGTR1—pancreatic cancer	6.82e-05	0.000105	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—BCL2L1—pancreatic cancer	6.78e-05	0.000105	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—NFKBIA—pancreatic cancer	6.78e-05	0.000105	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—PTEN—pancreatic cancer	6.77e-05	0.000104	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—STK11—pancreatic cancer	6.74e-05	0.000104	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—TSC2—pancreatic cancer	6.74e-05	0.000104	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—STK11—pancreatic cancer	6.72e-05	0.000104	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—APOE—pancreatic cancer	6.72e-05	0.000104	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CNR1—pancreatic cancer	6.71e-05	0.000104	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—NRAS—pancreatic cancer	6.66e-05	0.000103	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—SRC—pancreatic cancer	6.65e-05	0.000102	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—PIK3CA—pancreatic cancer	6.54e-05	0.000101	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—PTEN—pancreatic cancer	6.5e-05	0.0001	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—EGF—pancreatic cancer	6.49e-05	0.0001	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—GCG—pancreatic cancer	6.48e-05	0.0001	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—NRAS—pancreatic cancer	6.39e-05	9.86e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	6.33e-05	9.76e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—SRC—pancreatic cancer	6.28e-05	9.68e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—NOTCH1—pancreatic cancer	6.2e-05	9.56e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—AGTR1—pancreatic cancer	6.19e-05	9.54e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—NFKBIA—pancreatic cancer	6.15e-05	9.48e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—STK11—pancreatic cancer	6.1e-05	9.4e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—EGFR—pancreatic cancer	6.07e-05	9.35e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CDH1—pancreatic cancer	6.04e-05	9.31e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—NRAS—pancreatic cancer	6.04e-05	9.31e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—SRC—pancreatic cancer	6.03e-05	9.29e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—EGF—pancreatic cancer	5.99e-05	9.24e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—SMAD4—pancreatic cancer	5.89e-05	9.08e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—EGF—pancreatic cancer	5.88e-05	9.07e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—EGFR—pancreatic cancer	5.83e-05	8.98e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—TYMS—pancreatic cancer	5.8e-05	8.94e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—NRAS—pancreatic cancer	5.8e-05	8.94e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PIK3CD—pancreatic cancer	5.77e-05	8.9e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—HES1—pancreatic cancer	5.75e-05	8.86e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—KRAS—pancreatic cancer	5.73e-05	8.84e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—KRAS—pancreatic cancer	5.5e-05	8.48e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—EGFR—pancreatic cancer	5.5e-05	8.48e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CDH1—pancreatic cancer	5.48e-05	8.45e-05	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—AKT1—pancreatic cancer	5.34e-05	8.23e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—SMAD4—pancreatic cancer	5.34e-05	8.23e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PIK3CD—pancreatic cancer	5.33e-05	8.22e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—EGFR—pancreatic cancer	5.28e-05	8.14e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—PIK3CA—pancreatic cancer	5.27e-05	8.12e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PIK3CD—pancreatic cancer	5.23e-05	8.07e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—HES1—pancreatic cancer	5.21e-05	8.04e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—KRAS—pancreatic cancer	5.2e-05	8.01e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—PIK3CA—pancreatic cancer	5.06e-05	7.79e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TERT—pancreatic cancer	5.04e-05	7.77e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PIK3CB—pancreatic cancer	5.03e-05	7.76e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—KRAS—pancreatic cancer	4.99e-05	7.69e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—HRAS—pancreatic cancer	4.87e-05	7.51e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—HIF1A—pancreatic cancer	4.82e-05	7.43e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TSC2—pancreatic cancer	4.81e-05	7.41e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—PIK3CA—pancreatic cancer	4.77e-05	7.36e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—APOE—pancreatic cancer	4.72e-05	7.27e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—APOE—pancreatic cancer	4.7e-05	7.25e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—HRAS—pancreatic cancer	4.68e-05	7.21e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PIK3CB—pancreatic cancer	4.64e-05	7.16e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—KDR—pancreatic cancer	4.61e-05	7.1e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PTGS2—pancreatic cancer	4.6e-05	7.09e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—PIK3CA—pancreatic cancer	4.58e-05	7.07e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TERT—pancreatic cancer	4.57e-05	7.04e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PIK3CB—pancreatic cancer	4.56e-05	7.03e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.47e-05	6.89e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CTNNB1—pancreatic cancer	4.46e-05	6.88e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—HRAS—pancreatic cancer	4.42e-05	6.81e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NFKBIA—pancreatic cancer	4.38e-05	6.76e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—HIF1A—pancreatic cancer	4.37e-05	6.74e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TSC2—pancreatic cancer	4.36e-05	6.72e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PTEN—pancreatic cancer	4.35e-05	6.7e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NOTCH1—pancreatic cancer	4.34e-05	6.69e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—AKT1—pancreatic cancer	4.3e-05	6.63e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—APOE—pancreatic cancer	4.26e-05	6.57e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PIK3CG—pancreatic cancer	4.26e-05	6.56e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PIK3CG—pancreatic cancer	4.24e-05	6.54e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—HRAS—pancreatic cancer	4.24e-05	6.54e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—EGF—pancreatic cancer	4.2e-05	6.47e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—KDR—pancreatic cancer	4.18e-05	6.44e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—AKT1—pancreatic cancer	4.13e-05	6.37e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CTNNB1—pancreatic cancer	4.12e-05	6.35e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PPARG—pancreatic cancer	4.11e-05	6.34e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CTNNB1—pancreatic cancer	4.04e-05	6.23e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—SRC—pancreatic cancer	4.03e-05	6.21e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PTEN—pancreatic cancer	4.01e-05	6.19e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NFKBIA—pancreatic cancer	3.97e-05	6.13e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PTEN—pancreatic cancer	3.94e-05	6.08e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NOTCH1—pancreatic cancer	3.94e-05	6.07e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—AKT1—pancreatic cancer	3.9e-05	6.01e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—STAT3—pancreatic cancer	3.89e-05	5.99e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—NRAS—pancreatic cancer	3.88e-05	5.98e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PIK3CG—pancreatic cancer	3.85e-05	5.93e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—EGF—pancreatic cancer	3.8e-05	5.87e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—AKT1—pancreatic cancer	3.75e-05	5.77e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PIK3CD—pancreatic cancer	3.74e-05	5.77e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PIK3CD—pancreatic cancer	3.73e-05	5.75e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—SRC—pancreatic cancer	3.72e-05	5.74e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—SRC—pancreatic cancer	3.66e-05	5.64e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—STAT3—pancreatic cancer	3.59e-05	5.53e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—NRAS—pancreatic cancer	3.58e-05	5.52e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—EGFR—pancreatic cancer	3.53e-05	5.45e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—STAT3—pancreatic cancer	3.53e-05	5.43e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—NRAS—pancreatic cancer	3.52e-05	5.42e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PIK3CD—pancreatic cancer	3.38e-05	5.22e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—KRAS—pancreatic cancer	3.34e-05	5.15e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MYC—pancreatic cancer	3.34e-05	5.14e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—TGFB1—pancreatic cancer	3.33e-05	5.13e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PIK3CB—pancreatic cancer	3.26e-05	5.03e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—EGFR—pancreatic cancer	3.26e-05	5.03e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PIK3CB—pancreatic cancer	3.25e-05	5.01e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PTGS2—pancreatic cancer	3.23e-05	4.98e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—EGFR—pancreatic cancer	3.2e-05	4.94e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CXCL8—pancreatic cancer	3.13e-05	4.82e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—KRAS—pancreatic cancer	3.08e-05	4.75e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PIK3CA—pancreatic cancer	3.07e-05	4.73e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—KRAS—pancreatic cancer	3.03e-05	4.67e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CASP3—pancreatic cancer	2.99e-05	4.61e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PIK3CB—pancreatic cancer	2.95e-05	4.55e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CCND1—pancreatic cancer	2.91e-05	4.49e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CTNNB1—pancreatic cancer	2.88e-05	4.45e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—HRAS—pancreatic cancer	2.84e-05	4.37e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CXCL8—pancreatic cancer	2.83e-05	4.37e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PIK3CA—pancreatic cancer	2.83e-05	4.37e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MMP9—pancreatic cancer	2.83e-05	4.36e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PTEN—pancreatic cancer	2.82e-05	4.35e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PTEN—pancreatic cancer	2.81e-05	4.33e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PIK3CA—pancreatic cancer	2.78e-05	4.29e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CASP3—pancreatic cancer	2.71e-05	4.18e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CCND1—pancreatic cancer	2.64e-05	4.07e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—HRAS—pancreatic cancer	2.62e-05	4.04e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CTNNB1—pancreatic cancer	2.61e-05	4.03e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—SRC—pancreatic cancer	2.61e-05	4.02e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—HRAS—pancreatic cancer	2.57e-05	3.97e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MMP9—pancreatic cancer	2.56e-05	3.95e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PTEN—pancreatic cancer	2.55e-05	3.93e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—VEGFA—pancreatic cancer	2.54e-05	3.91e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—STAT3—pancreatic cancer	2.51e-05	3.88e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NRAS—pancreatic cancer	2.51e-05	3.87e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—AKT1—pancreatic cancer	2.51e-05	3.86e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—SRC—pancreatic cancer	2.36e-05	3.64e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MYC—pancreatic cancer	2.34e-05	3.6e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TGFB1—pancreatic cancer	2.33e-05	3.59e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—AKT1—pancreatic cancer	2.31e-05	3.57e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—VEGFA—pancreatic cancer	2.3e-05	3.55e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—EGFR—pancreatic cancer	2.28e-05	3.52e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—STAT3—pancreatic cancer	2.28e-05	3.51e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NRAS—pancreatic cancer	2.27e-05	3.51e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—AKT1—pancreatic cancer	2.27e-05	3.5e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—KRAS—pancreatic cancer	2.16e-05	3.33e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MYC—pancreatic cancer	2.12e-05	3.27e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TGFB1—pancreatic cancer	2.11e-05	3.26e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—EGFR—pancreatic cancer	2.07e-05	3.19e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PIK3CA—pancreatic cancer	1.99e-05	3.07e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PIK3CA—pancreatic cancer	1.98e-05	3.06e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—KRAS—pancreatic cancer	1.96e-05	3.02e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TP53—pancreatic cancer	1.92e-05	2.96e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—HRAS—pancreatic cancer	1.83e-05	2.83e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PIK3CA—pancreatic cancer	1.8e-05	2.77e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TP53—pancreatic cancer	1.74e-05	2.68e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—HRAS—pancreatic cancer	1.66e-05	2.56e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—AKT1—pancreatic cancer	1.62e-05	2.5e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—AKT1—pancreatic cancer	1.62e-05	2.5e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—AKT1—pancreatic cancer	1.47e-05	2.26e-05	CbGpPWpGaD
